KingstronBio
Latest round
- Series C
Last raised
- Nov 2021
Total raised
- $67M
Investors
- 9
About KingstronBio
Based in Changshu, China and established in 2012, KingStronBio is a medical device company that is R&D, and production of cardiovascular device. The company covered more than 20 acres, which factory integrated R&D and production has been built and put into use, and is building high-end cardiovascular device manufacture base. The company provides products include surgical biological valves, valvulopasty rings, biological patches, interventional mitral valves, interventional tricuspid valves, transcatheter aortic valve implantation (TAVR). Up to 2021, The surgical line valve forming ring, and surgical bioprosthetic valve products have been sold. The third generation transcatheter aortic valve system is about to complete clinical trials. The company plans to promote the development of mitral and tricuspid valves products, and registration of third-generation TAVR products. Also, it will mass production of surgical biological valves, biological patches.
Who invested in KingstronBio
9 investors across 3 rounds
See all investors in KingstronBio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about KingstronBio
Who invested in KingstronBio?
KingstronBio has 9 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has KingstronBio raised?
KingstronBio has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did KingstronBio last raise money?
KingstronBio's most recent round on record is a Series C, in Nov 2021.
What does KingstronBio do?
Based in Changshu, China and established in 2012, KingStronBio is a medical device company that is R&D, and production of cardiovascular device.
Where is KingstronBio headquartered?
KingstronBio is headquartered in Suzhou, China.
Which VCs invest in companies like KingstronBio?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at KingstronBio's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series C
Raising like KingstronBio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.